Healthcare Stocks
335 stocks listed in India are classified under Healthcare, sorted by market cap. The largest is Sun Pharma.
Data as of 04 Nov 2026
- Stocks
- 335
- Total market cap
- ₹35.17 L Cr
- Sector P/E (weighted by market cap)
- 41.7
- Median 1M
- −2.1%
- Median 1Y
- −5.1%
Figures cover 326 of 335 companies, those with market data. 52 reported a loss and are left out of the P/E.
Biggest moves this month
Top gainers, 1M
- Piramal Pharma +22.0%
- Acutaas Chemicals +21.0%
- Laurus Labs +17.9%
- Syngene International +16.8%
- Dr Reddys Laboratories +14.2%
Top losers, 1M
- Neuland Laboratories −10.5%
- Shilpa Medicare −9.7%
- Wockhardt −8.0%
- GlaxoSmithKline Pharmaceuticals −7.4%
- Caplin Point Laboratories −7.2%
All Healthcare Stocks
1–100 of 335, by market cap
| Company | Price | Market Cap | P/E | 1M | 1Y |
|---|---|---|---|---|---|
| Sun Pharma | ₹1,773.40 | ₹4.29 L Cr | 38.8 | −0.4% | +4.9% |
| Divis Laboratories | ₹10,037.50 | ₹2.65 L Cr | 91.1 | +9.2% | +47.5% |
| Torrent Pharmaceuticals | ₹4,738.50 | ₹1.77 L Cr | 78.6 | −0.7% | +32.6% |
| Zydus Life Science | ₹1,188.10 | ₹1.25 L Cr | 26.4 | +4.3% | +22.3% |
| Laurus Labs | ₹2,323.80 | ₹1.25 L Cr | 114.8 | +17.9% | +136.4% |
| Apollo Hospitals | ₹8,599.50 | ₹1.23 L Cr | 59.2 | +7.7% | +10.1% |
| Dr Reddys Laboratories | ₹1,374.00 | ₹1.15 L Cr | 35.6 | +14.2% | +14.5% |
| Cipla | ₹1,402.00 | ₹1.12 L Cr | 33.6 | +5.0% | −6.7% |
| Mankind Pharma | ₹2,537.90 | ₹1.03 L Cr | 51.3 | +2.4% | +7.1% |
| Aurobindo Pharma | ₹1,705.00 | ₹97,918 Cr | 26.6 | +1.8% | +48.4% |
| Lupin | ₹2,008.60 | ₹92,784 Cr | 16.6 | −0.1% | +0.6% |
| Max Healthcare Institute | ₹927.15 | ₹89,301 Cr | 61.9 | +1.1% | −18.6% |
| Glenmark Pharmaceuticals | ₹2,504.70 | ₹67,652 Cr | 39.3 | +9.1% | +35.8% |
| Alkem Laboratories | ₹5,216.50 | ₹62,281 Cr | 28.9 | +0.5% | −7.9% |
| Aster DM Healthcare | ₹719.55 | ₹59,927 Cr | 117.0 | +4.1% | +4.5% |
| Fortis Healthcare | ₹790.65 | ₹59,706 Cr | 57.0 | +3.5% | −22.4% |
| Biocon | ₹344.45 | ₹56,379 Cr | 102.5 | −6.9% | −9.5% |
| Abbott | ₹27,120.00 | ₹55,068 Cr | 35.7 | +3.4% | −7.6% |
| Gland Pharma | ₹3,159.00 | ₹51,731 Cr | 46.1 | +8.5% | +65.2% |
| IPCA Laboratories | ₹1,972.00 | ₹50,188 Cr | 38.2 | +1.1% | +52.3% |
| Anthem Biosciences | ₹888.30 | ₹47,903 Cr | 86.7 | +4.3% | +26.5% |
| GlaxoSmithKline Pharmaceuticals | ₹2,531.80 | ₹43,404 Cr | 40.2 | −7.4% | −4.8% |
| Ajanta Pharma | ₹3,316.70 | ₹41,338 Cr | 36.5 | −4.9% | +27.0% |
| Emcure Pharmaceuticals | ₹2,160.40 | ₹40,344 Cr | 40.5 | +11.5% | +63.1% |
| Narayana Hrudayalaya | ₹1,931.50 | ₹39,090 Cr | 48.4 | +12.1% | +5.5% |
| Global Health | ₹1,402.00 | ₹37,618 Cr | 67.8 | +5.2% | +12.2% |
| Sai Life Sciences | ₹1,546.10 | ₹32,405 Cr | 90.3 | +2.3% | +67.5% |
| Dr Lal Pathlabs | ₹2,029.40 | ₹32,036 Cr | 62.8 | +3.0% | +28.7% |
| Piramal Pharma | ₹237.76 | ₹31,413 Cr | — | +22.0% | +18.6% |
| Acutaas Chemicals | ₹3,777.30 | ₹31,154 Cr | 80.1 | +21.0% | +105.9% |
| Krishna Institute of Medical Sciences | ₹740.55 | ₹30,912 Cr | 146.6 | +5.0% | +3.3% |
| Wockhardt | ₹1,899.00 | ₹30,698 Cr | 75.5 | −8.0% | +39.1% |
| Rubicon Research | ₹1,716.80 | ₹28,405 Cr | 97.0 | +6.7% | +163.1% |
| Neuland Laboratories | ₹19,576.00 | ₹25,039 Cr | 50.5 | −10.5% | +11.2% |
| Granules | ₹794.60 | ₹19,505 Cr | 29.5 | −2.8% | +40.0% |
| Onesource Specialty Pharma | ₹1,583.60 | ₹18,106 Cr | — | +6.4% | −13.6% |
| Alivus Life Sciences | ₹1,520.70 | ₹18,070 Cr | 30.9 | +10.7% | +68.2% |
| Caplin Point Laboratories | ₹2,416.10 | ₹17,984 Cr | 27.6 | −7.2% | +21.1% |
| Shilpa Medicare | ₹931.10 | ₹17,823 Cr | 61.3 | −9.7% | +160.5% |
| Pfizer | ₹3,834.70 | ₹17,805 Cr | 23.9 | −0.2% | −25.0% |
| Cohance Lifesciences | ₹450.45 | ₹16,972 Cr | 162.0 | +0.8% | −39.4% |
| Dr Agarwals Health Care | ₹523.50 | ₹16,542 Cr | 111.6 | +8.1% | +1.6% |
| Syngene International | ₹417.50 | ₹16,536 Cr | 76.0 | +16.8% | −35.4% |
| Eris Lifesciences | ₹1,215.00 | ₹16,404 Cr | 26.0 | +2.2% | −24.1% |
| Alembic Pharmaceuticals | ₹906.70 | ₹16,169 Cr | 25.7 | +9.1% | −5.6% |
| AstraZeneca Pharma | ₹6,368.00 | ₹15,834 Cr | 93.8 | +7.8% | −33.7% |
| Natco Pharma | ₹788.75 | ₹15,532 Cr | 13.5 | −4.0% | −3.8% |
| Poly Medicure | ₹1,586.80 | ₹15,325 Cr | 51.0 | −2.0% | −18.8% |
| Jubilant Pharmova | ₹939.55 | ₹15,094 Cr | 42.5 | −4.3% | −20.5% |
| Indegene | ₹617.10 | ₹14,947 Cr | 37.0 | +3.1% | +14.5% |
| Vijaya Diagnostic Centre | ₹1,424.60 | ₹14,588 Cr | 78.2 | +0.2% | +39.0% |
| Marksans Pharma | ₹301.65 | ₹14,562 Cr | 26.4 | −9.1% | +61.5% |
| Corona Remedies | ₹2,405.80 | ₹14,025 Cr | 74.1 | +18.3% | — |
| Rainbow Childrens Medicare | ₹1,279.60 | ₹12,961 Cr | 45.5 | +0.8% | −8.0% |
| Concord Biotech | ₹655.50 | ₹12,834 Cr | 24.3 | −3.3% | −9.9% |
| Sudeep Pharma | ₹1,116.70 | ₹12,439 Cr | 66.3 | −4.8% | — |
| Akums Drugs & Pharma | ₹751.50 | ₹11,537 Cr | 40.6 | −6.2% | +59.5% |
| Metropolis Healthcare | ₹581.25 | ₹11,437 Cr | 59.7 | +5.0% | +14.5% |
| Park Medi World | ₹230.45 | ₹9,956 Cr | 34.8 | −13.9% | — |
| Yatharth Hospital | ₹1,027.90 | ₹9,925 Cr | 54.7 | +2.5% | +25.1% |
| Viyash Scientific | ₹228.46 | ₹9,922 Cr | 39.7 | −0.3% | +4.3% |
| Procter & Gamble Health | ₹5,738.00 | ₹9,643 Cr | 26.7 | +8.3% | −5.4% |
| Blue Jet Healthcare | ₹531.85 | ₹9,569 Cr | 39.3 | +0.1% | −12.3% |
| Strides Pharma Science | ₹1,014.20 | ₹9,485 Cr | 15.2 | −6.7% | +5.3% |
| Healthcare Global Enterprises | ₹621.35 | ₹9,172 Cr | 406.1 | −7.1% | −18.0% |
| Jupiter Life Line Hospital | ₹279.55 | ₹8,792 Cr | 48.9 | +10.1% | −10.1% |
| Aarti Pharmalabs | ₹926.50 | ₹8,311 Cr | 39.4 | −2.1% | +9.7% |
| Sanofi Consumer Healthcare | ₹3,472.60 | ₹8,015 Cr | 30.1 | −7.5% | −28.9% |
| Sanofi | ₹3,450.80 | ₹7,821 Cr | 24.5 | +14.1% | −27.4% |
| Thyrocare Technologies | ₹495.50 | ₹7,723 Cr | 44.7 | −8.6% | +9.6% |
| Suven Life Sciences | ₹276.10 | ₹7,549 Cr | — | −9.9% | +39.9% |
| Supriya Lifescience | ₹859.90 | ₹6,796 Cr | 34.9 | −4.4% | +8.0% |
| Bliss GVS Pharma | ₹619.55 | ₹6,695 Cr | 48.2 | −6.8% | +302.9% |
| Kovai Medical Center Hospital | ₹5,995.00 | ₹6,477 Cr | 25.6 | +0.5% | −2.0% |
| FDC | ₹390.95 | ₹6,359 Cr | 21.8 | +18.0% | −12.6% |
| Nephrocare Health Services | ₹622.35 | ₹5,903 Cr | 148.5 | −2.4% | — |
| Sun Pharma Advanced Research Co | ₹185.33 | ₹5,820 Cr | 3.8 | −3.1% | +35.7% |
| Innova Captab | ₹1,035.00 | ₹5,672 Cr | 38.5 | −9.6% | +25.2% |
| Morepen Laboratories | ₹101.33 | ₹5,326 Cr | 39.4 | −25.1% | +110.2% |
| Senores Pharmaceuticals | ₹1,137.00 | ₹5,250 Cr | 41.5 | −13.9% | +48.3% |
| IOL Chemicals & Pharmaceuticals | ₹183.77 | ₹5,219 Cr | 32.1 | −10.7% | +98.1% |
| Orchid Pharma | ₹876.75 | ₹5,149 Cr | 417.5 | −9.2% | +10.9% |
| Gujarat Themis Biosyn | ₹387.75 | ₹4,924 Cr | 86.7 | +3.8% | −15.8% |
| SMS Pharmaceuticals | ₹525.50 | ₹4,755 Cr | 48.1 | +10.0% | +87.1% |
| Artemis Medicare Services | ₹300.25 | ₹4,740 Cr | 40.5 | −7.4% | +22.5% |
| Novartis | ₹1,714.30 | ₹4,257 Cr | 43.3 | −12.9% | +155.0% |
| RPG Life Sciences | ₹2,598.50 | ₹4,251 Cr | 36.0 | −10.3% | +5.5% |
| Aarti Drugs | ₹455.80 | ₹4,247 Cr | 21.8 | +9.8% | −9.5% |
| Zota Healthcare | ₹1,217.90 | ₹4,239 Cr | — | −6.1% | −22.0% |
| Gufic BioSciences | ₹428.90 | ₹4,231 Cr | 58.5 | +2.2% | +31.2% |
| Jeena Sikho Lifecare | ₹336.65 | ₹4,227 Cr | 17.7 | −25.2% | −57.0% |
| Kwality Pharmaceuticals | ₹3,741.00 | ₹3,728 Cr | 47.9 | +2.7% | +316.5% |
| Unichem Laboratories | ₹505.45 | ₹3,651 Cr | 11.7 | −4.9% | +8.1% |
| Shukra Pharmaceuticals | ₹79.87 | ₹3,551 Cr | 98.6 | +13.3% | +102.8% |
| Advanced Enzyme Tech | ₹278.40 | ₹3,125 Cr | 18.8 | +2.2% | −11.3% |
| Ind Swift Laboratories | ₹370.55 | ₹3,098 Cr | 55.1 | −3.9% | +264.7% |
| Solara Active Pharma Sciences | ₹644.90 | ₹3,038 Cr | 91.2 | −4.7% | +4.5% |
| Indraprastha Medical Corporation | ₹336.30 | ₹2,953 Cr | 16.4 | +0.7% | −44.3% |
| Hikal | ₹222.63 | ₹2,679 Cr | — | +3.8% | −7.4% |
| Dr Agarwals Eye Hospital | ₹5,423.00 | ₹2,549 Cr | 34.4 | +4.0% | +2.6% |
Industries in Healthcare
Related sectors
Healthcare stocks: common questions
How many Healthcare stocks are listed in India?
335 stocks are classified under Healthcare on Tapetide. They span Pharma, Hospital & Healthcare Services, Healthcare Equipment.
Which is the largest Healthcare company by market cap?
Sun Pharma, at ₹4.29 L Cr. It is followed by Divis Laboratories and Torrent Pharmaceuticals.
What is the P/E ratio of the Healthcare sector?
41.7, weighted by market cap: the sector's total market cap divided by its total trailing twelve-month profit. 52 of its companies reported a loss and are left out of the ratio.
How have Healthcare stocks performed over the last year?
The median Healthcare stock moved −5.1% over the past year.